首页> 美国政府科技报告 >Direct radiolabeling of the somatostatin analogs RC-160 and octreotide with (sup 99m)Tc and (sup 188)Re: Initial results with stannous reductions
【24h】

Direct radiolabeling of the somatostatin analogs RC-160 and octreotide with (sup 99m)Tc and (sup 188)Re: Initial results with stannous reductions

机译:直接放射性标记生长抑素类似物RC-160和奥曲肽与(sup 99m)Tc和(sup 188)Re:初始结果用亚锡减少

获取原文

摘要

Reductive insertion of (sup 99m)Tc and rhenium between cysteine residues of cyclic peptides is a possible technique for the direct labeling of somatostatin analogues. Such a labeling technique could also be applicable to labeling with (sup 188)Re and consequently is of general interest in regard to cyclic peptides and specific interest in regard to potential clinical applications of somatostatin analogues. In this study, the somatostatin analogues octreotide and RC-160 were evaluated after direct labeling with (sup 99m)Tc and (sup 188)Re. The peptide analogues were prepared as cold kits, and labeled on demand as needed. Both peptides were found to be easily and reproducibly radiolabeled with both radionuclides with labeling efficiencies greater than 95% as determined by TLC.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号